TRCT
VMD icon

Tower Research Capital (TRC)’s Viemed Healthcare VMD Stock Holding History

Tower Research Capital (TRC)’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34K Buy
2,980
+1
+0% +$10 ﹤0.01% 3073
2026
Q1 		$27.4K Buy
2,979
+1,257
+73% +$10.5K ﹤0.01% 3250
2025
Q4 		$12.8K Buy
1,722
+381
+28% +$2.61K ﹤0.01% 3449
2025
Q3 		$9.11K Sell
1,341
-4,117
-75% -$27.9K ﹤0.01% 4037
2025
Q2 		$37.7K Buy
5,458
+4,122
+309% +$28K ﹤0.01% 3215
2025
Q1 		$9.73K Buy
1,336
+123
+10% +$966 ﹤0.01% 3738
2024
Q4 		$9.73K Sell
1,213
-1,034
-46% -$8.97K ﹤0.01% 3880
2024
Q3 		$16.5K Sell
2,247
-5,020
-69% -$35.9K ﹤0.01% 3360
2024
Q2 		$47.6K Buy
7,267
+6,302
+653% +$47.5K ﹤0.01% 3139
2024
Q1 		$9.1K Sell
965
-2,284
-70% -$19.6K ﹤0.01% 3898
2023
Q4 		$25.5K Buy
3,249
+1,191
+58% +$8.64K ﹤0.01% 3509
2023
Q3 		$13.8K Buy
2,058
+960
+87% +$7.87K ﹤0.01% 3744
2023
Q2 		$10.7K Sell
1,098
-710
-39% -$7.21K ﹤0.01% 4073
2023
Q1 		$17K Buy
1,808
+945
+110% +$8.24K ﹤0.01% 3653
2022
Q4 		$7K Sell
863
-962
-53% -$6.51K ﹤0.01% 4628
2022
Q3 		$11K Sell
1,825
-9,575
-84% -$61.5K ﹤0.01% 4470
2022
Q2 		$61K Buy
11,400
+8,932
+362% +$48.1K ﹤0.01% 2706
2022
Q1 		$12K Sell
2,468
-17,398
-88% -$80.8K ﹤0.01% 4105
2021
Q4 		$104K Buy
19,866
+2,032
+11% +$11.3K ﹤0.01% 2196
2021
Q3 		$99K Buy
17,834
+13,073
+275% +$85.1K ﹤0.01% 2411
2021
Q2 		$34K Buy
4,761
+986
+26% +$8.54K ﹤0.01% 3367
2021
Q1 		$38K Sell
3,775
-1,751
-32% -$16.5K ﹤0.01% 3361
2020
Q4 		$43K Sell
5,526
-31,722
-85% -$279K ﹤0.01% 3263
2020
Q3 		$321K Buy
37,248
+5,034
+16% +$50.8K ﹤0.01% 2120
2020
Q2 		$309K Buy
+32,214
New +$250K 0.01% 1418

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Tower Research Capital (TRC)'s VMD Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Viemed Healthcare (VMD) stake by 0.03% in Q2 2026, buying an estimated $10 and bringing the position to 2,980 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #3073.

Tower Research Capital (TRC) first reported a position in VMD in Q2 2020 and has held it in 25 quarters since. The position peaked at $321K in Q3 2020. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Tower Research Capital (TRC) held 2,980 shares of Viemed Healthcare worth $34K as of Q2 2026.
  • Tower Research Capital (TRC) bought 1 Viemed Healthcare share in Q2 2026, an estimated $10.
  • Viemed Healthcare made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3073 holding.
  • Tower Research Capital (TRC) first reported a position in Viemed Healthcare in Q2 2020 and has held it in 25 quarters since.
  • Tower Research Capital (TRC)'s Viemed Healthcare position peaked at $321K in Q3 2020.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.